INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Instituto IMDEA Alimentación
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto IMDEA Alimentación (7)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Mitochondrial RNA methyltransferase TRMT61B is a new, potential biomarker and therapeutic target for highly aneuploid cancers
Cell Death and Differentiation, Vol. 30, Núm. 1, pp. 37-53
-
NOX2 and NOX4 control mitochondrial function in chronic myeloid leukaemia
Free Radical Biology and Medicine, Vol. 198, pp. 92-108
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
ACx43 peptide inhibits metabolic plasticity in human glioma stem cells while sparing human neural stem cells and astrocytes
XV European Meeting on Glial Cells in Health and Disease
-
Erratum to “Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283” [EBioMedicine 62, December 2020] DOI: https://doi.org/10.1016/j.ebiom.2020.103134 (EBioMedicine (2020) 62, (S2352396420305107), (10.1016/j.ebiom.2020.103134))
EBioMedicine
2015
-
ColoLipidGene: Signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients
Oncotarget, Vol. 6, Núm. 9, pp. 7348-7363